The randomized study revealed significant clinical advantages of Kiva over balloon kyphoplasty. Kiva considerably restored vertebral body wedge deformity and showed noticeably lower rates of extravasation and cement volume than balloon kyphoplasty.
The Kiva VCF Treatment System, a flexible implant made of a biocompatible polymer, offers an alternative method for the treatment of VCFs.
More Articles on Spine Devices and Implants:
Minimally Invasive Spine Market Expected to Top $2B by 2017
5 Recent Spine-Focused Device Company Financial Reports
ApiFix Receives CE Mark for Scoliosis Treatment Device
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.